Clinical Trial Update: Expanded Haploidentical Natural Killer Cells as Consolidation Strategy for Children/Young Adults With AML [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating expanded haploidentical natural killer cells as a consolidation therapy for children and young adults with acute myeloid l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Expanded haploidentical natural killer cells (haploidentical natural killer cell therapy)

Snippet

Sponsor: Belarusian Research Center for Pediatric Oncology, Hematology and Immunology | Conditions: Acute Myeloid Leukemia | Phase 1, Phase 2 | Status: RECRUITING